1,559 results on '"Oshima, H"'
Search Results
402. HDTV Digital VCR for Broadcast-use Employing Bit Rate Reduction
- Author
-
Oshima, H.
- Published
- 1994
- Full Text
- View/download PDF
403. Inflammation-induced repression of tumor suppressor miR-7 in gastric tumor cells.
- Author
-
Kong, D, Piao, Y-S, Yamashita, S, Oshima, H, Oguma, K, Fushida, S, Fujimura, T, Minamoto, T, Seno, H, Yamada, Y, Satou, K, Ushijima, T, Ishikawa, T-O, and Oshima, M
- Subjects
- *
INFLAMMATION , *GENE expression , *TUMOR suppressor genes , *CANCER cells , *TUMOR growth , *MICRORNA , *CARCINOGENESIS , *LABORATORY mice - Abstract
Inflammation has an important role in cancer development through various mechanisms. It has been shown that dysregulation of microRNAs (miRNAs) that function as oncogenes or tumor suppressors contributes to tumorigenesis. However, the relationship between inflammation and cancer-related miRNA expression in tumorigenesis has not yet been fully understood. Using K19-C2mE and Gan mouse models that develop gastritis and gastritis-associated tumors, respectively, we found that 21 miRNAs were upregulated, and that 29 miRNAs were downregulated in gastric tumors in an inflammation-dependent manner. Among these miRNAs, the expression of miR-7, a possible tumor suppressor, significantly decreased in both gastritis and gastric tumors. Moreover, the expression of miR-7 in human gastric cancer was inversely correlated with the levels of interleukin-1β and tumor necrosis factor-α, suggesting that miR-7 downregulation is related to the severity of inflammatory responses. In the normal mouse stomach, miR-7 expression was at a basal level in undifferentiated gastric epithelial cells, and was induced during differentiation. Moreover, transfection of a miR-7 precursor into gastric cancer cells suppressed cell proliferation and soft agar colony formation. These results suggest that suppression of miR-7 expression is important for maintaining the undifferentiated status of gastric epithelial cells, and thus contributes to gastric tumorigenesis. Although epigenetic changes were not found in the CpG islands around miR-7-1 of gastritis and gastric tumor cells, we found that activated macrophage-derived small molecule(s) (<3 kDa) are responsible for miR-7 repression in gastric cancer cells. Furthermore, the miR-7 expression level significantly decreased in the inflamed gastric mucosa of Helicobacter-infected mice, whereas it increased in the stomach of germfree K19-C2mE and Gan mice wherein inflammatory responses were suppressed. Taken together, these results indicate that downregulation of tumor suppressor miR-7 is a novel mechanism by which the inflammatory response promotes gastric tumorigenesis. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
404. Electronic structures of HOPG and stage-2 IBr-GIC studied by angle resolved photoemission
- Author
-
Negishi, H., Negishi, S., Shimada, K., Narimura, T., Higashiguchi, M., Namatame, H., Taniguchi, M., Kobayashi, K., Sugihara, K., and Oshima, H.
- Subjects
- *
ELECTRONIC structure , *PHOTOEMISSION , *ELECTRON emission , *SPECTRUM analysis - Abstract
Abstract: Angle resolved photoemission spectra (ARPES) of host HOPG and IBr-GIC have been measured at 16K using hν=122eV. Both HOPG and IBr-GIC show clear dispersions of upper π band and σ bands derived from C 2s and 2p electrons. The intensity plot of ARPES spectra shows the overlap of the dispersion curves along the ΓM and ΓK directions due to the in-plane mosaic structure of HOPG. Based on the Johnson–Dresselhaus band model, the dispersion curves of the π bands of HOPG and IBr-GIC are reproduced over the full Brillouin zone. We discuss the important role of the interactions between C–C atoms in the neighboring layers in the stage-2 structure. [Copyright &y& Elsevier]
- Published
- 2006
- Full Text
- View/download PDF
405. Nano-oxide fabrication on thin-films of 3d-metal compounds and alloys
- Author
-
Kuramochi, H., Tokizaki, T., Onuki, T., Okabayashi, J., Mizuguchi, M., Takano, F., Oshima, H., Manago, T., Akinaga, H., and Yokoyama, H.
- Subjects
- *
THIN films , *ALLOYS , *SOLID state electronics , *SURFACES (Technology) - Abstract
Nanometer-scale structures were fabricated by anodic oxidation using scanning probe microscopes on thin-films of various 3d-metal compounds and alloys on GaAs, such as MnAs, MnSb, Cr2O3, CoCr and NiFe. Material variation advances the developments in nano-fabrication by scanning probe microscope. Comparing the oxidation conditions, new methodology for fabrication of nano-devices is explored. [Copyright &y& Elsevier]
- Published
- 2004
- Full Text
- View/download PDF
406. Measurement of hydrogen concentration in thick mineral or rock samples
- Author
-
Furuno, K., Komatsubara, T., Sasa, K., Oshima, H., Yamato, Y., Ishii, S., Kimura, H., and Kurosawa, M.
- Subjects
- *
PROTON beams , *SPECTRUM analysis , *HYDROGEN , *ROCKS - Abstract
This paper describes an application of a proton–proton elastic recoil coincidence spectroscopy to hydrogen analysis using a proton microbeam at an energy of 20 MeV. This method provides depth profiles of hydrogen over a thickness of 200 μm of silicate samples in a short time. A typical beam size is as small as 27 × 32 μm. The depth resolution is about 10 μm. The present work proves that the proton–proton elastic recoil coincidence spectroscopy is a promising method for measurements of hydrogen in mineral and rock samples with thickness up to 200 μm. [Copyright &y& Elsevier]
- Published
- 2003
- Full Text
- View/download PDF
407. 073041 (M54) - Recent circumstances in regard to the liability systems in Japan
- Author
-
Oshima, H. and Go, H.
- Published
- 1995
- Full Text
- View/download PDF
408. Endogenous production of tumor necrosis factor by a combination of interferon and BRM of bacterial origin
- Author
-
Satoh, M., Inagawa, H., Minagawa, H., Kajikawa, T., Oshima, H., Abe, S., Yamazaki, M., and Mizuno, D.
- Published
- 1985
- Full Text
- View/download PDF
409. Photoemission study of the IBr graphite intercalation compound using the synchrotron radiation light source
- Author
-
Negishi, S., Negishi, H., Nakatake, M., Yamazaki, K., Sato, H., Shimada, K., Namatame, H., Taniguchi, M., Kobayashi, K., Sugihara, K., and Oshima, H.
- Subjects
- *
PHOTOEMISSION , *ELECTRON emission , *CLATHRATE compounds , *SYNCHROTRON radiation - Abstract
Abstract: We measured the photoemission spectra of the IBr graphite intercalation compounds (IBr–GIC) with stage-2 and stage-4 structures at 16K with incident photon energies hν=40–200eV. The peak positions of the I 4d and Br 3d core-levels are unchanged for the stage-2 and stage-4 IBr–GICs. Partial density-of-states of the I 5p and Br 4p states in the valence bands have been evaluated by resonant photoemission spectroscopy. These spectra indicate a significant hybridization between the host and the guest IBr in the van der Waals gap. [Copyright &y& Elsevier]
- Published
- 2006
- Full Text
- View/download PDF
410. A strong enhancement of CPP-GMR by using large resistivity magnetic materials
- Author
-
Jogo, A., Nagasaka, K., Ibusuki, T., Oshima, H., Shimizu, Y., Uzumaki, T., and Tanaka, A.
- Subjects
- *
FERROMAGNETIC materials , *MAGNETORESISTANCE , *SPIN valves , *TRANSITION metal alloys - Abstract
Abstract: We found a ferromagnetic material Co–Mn–Al that shows large specific magnetoresistance change (ΔRA) in the fully metallic current-perpendicular-to-plane (CPP) spin valve system when used for pinned and free layers. The Co–Mn–Al films were sputter-deposited at room temperature and have disorderd crystral structure. Analyzing the experimental results with the semiclassical two-current theory, we concluded that the enhancement in ΔRA is ascribed to compatibility of high resistivity and a large spin-asymmetry coefficient for the spin-dependent bulk scattering of the alloy. The results were compared with those for the conventional Co–Fe alloy and for a Co–Fe–Al alloy that also shows large ΔRA. [Copyright &y& Elsevier]
- Published
- 2007
- Full Text
- View/download PDF
411. Allosteric Changes in the Conformational Landscape of Src Kinase upon Substrate Binding.
- Author
-
Chong SH, Oshima H, and Sugita Y
- Abstract
Precise regulation of protein kinase activity is crucial in cell functions, and its loss is implicated in various diseases. The kinase activity is regulated by interconverting active and inactive states in the conformational landscape. However, how protein kinases switch conformations in response to different signals such as the binding at distinct sites remains incompletely understood. Here, we predict the binding mode for the peptide substrate to Src tyrosine kinase using enhanced conformational sampling simulations (totaling 24 μs) and then investigate changes in the conformational landscape upon substrate binding by conducting unbiased molecular dynamics simulations (totaling 50 μs) initiated from the apo and substrate-bound forms. Unexpectedly, the peptide substrate binding significantly facilitates the transitions from active to inactive conformations in which the αC helix is directed outward, the regulatory spine is broken, and the ATP-binding domain is perturbed. We also explore an underlying residue-contact network responsible for the allosteric conformational changes. Our results are in accord with the recent experiments reporting the negative cooperativity between the peptide substrate and ATP binding to tyrosine kinases and will contribute to advancing our understanding of the regulation mechanisms for kinase activity., (Copyright © 2024. Published by Elsevier Ltd.)
- Published
- 2024
- Full Text
- View/download PDF
412. Intraoperative neuromonitoring of visual evoked potentials in a pregnant patient with meningioma: a case report.
- Author
-
Mori F, Sumi K, Watanabe M, Shijo K, Yumoto M, Oshima H, Fukaya C, Otani N, and Yoshino A
- Subjects
- Humans, Female, Pregnancy, Adult, Benzodiazepines therapeutic use, Benzodiazepines administration & dosage, Evoked Potentials, Visual physiology, Meningioma surgery, Intraoperative Neurophysiological Monitoring methods, Meningeal Neoplasms surgery, Pregnancy Complications, Neoplastic surgery
- Abstract
Background: Meningioma in the parasellar region may lead to visual impairment, so intraoperative neurological monitoring is essential for enucleation surgery. However, intraoperative neurological monitoring in pregnant women is challenging, as the anesthesia management must consider the effects and risks to the fetus. Remimazolam is a newly introduced intravenous anesthetic that has little effect on blood pressure. However, the effects of remimazolam on intraoperative neuromonitoring are little known. We treated a pregnant patient with parasellar meningioma who developed visual impairment, using remimazolam for anesthesia and intraoperative neurophysiological monitoring of the visual evoked potential., Case Presentation: A 34-year-old woman who was 20 weeks pregnant presented with visual acuity disturbances. Neuroimaging demonstrated a parasellar meningioma, and rapid tumor growth and worsening of symptoms subsequently occurred. Craniotomy for tumor removal was performed under anesthesia with remimazolam, which allowed monitoring of the visual evoked potentials. Her visual acuity was restored postoperatively, and no adverse events occurred in the fetus., Conclusion: Our experience with intraoperative neuromonitoring of a pregnant woman in the third trimester showed that anesthesia with remimazolam allows safe brain surgery combined with intraoperative visual evoked potential monitoring. Further research is needed to determine the effects of remimazolam on the fetus, as well as the safe dosage and duration of exposure., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
413. Comprehensive antitumor immune response boosted by dual inhibition of SUMOylation and MEK in MYC-expressing KRAS-mutant cancers.
- Author
-
Kotani H, Yamano T, Boucher JC, Sato S, Sakaguchi H, Fukuda K, Nishiyama A, Yamashita K, Ohtsubo K, Takeuchi S, Nishiuchi T, Oshima H, Oshima M, Davila ML, and Yano S
- Abstract
Precision medicine has drastically changed cancer treatment strategies including KRAS-mutant cancers which have been undruggable for decades. While intrinsic or acquired treatment resistance remains unresolved in many cases, epigenome-targeted therapy may be an option to overcome. We recently discovered the effectiveness of blocking small ubiquitin-like modifier (SUMO) signaling cascade (SUMOylation) in MYC-expressing KRAS-mutant cancer cells using a SUMO-activating enzyme E inhibitor TAK-981 that results in SUMOylation inhibition. Interestingly, TAK-981 promoted the degradation of MYC via the ubiquitin-proteasome system. Moreover, combination therapy with TAK-981 and MEK inhibitor trametinib remarkably regressed xenografted KRAS-mutant tumors by accumulating DNA damage and inducing apoptosis. Whereas our recent study revealed immune-independent antitumor efficacy, we evaluated the immune responses of cancer cells and immune cells in this study. We found that TAK-981-induced MYC downregulation promoted the activation of STING followed by Stat1 and MHC class I in KRAS-mutant cancer cells. Activation of dendritic cells or T cells treated with TAK-981 was also verified by upregulated activation markers in dendritic cells or skew-toward effector-like phenotypes in T cells. Furthermore, the enhanced immune-dependent antitumor efficacy of the combination therapy with TAK-981 and trametinib was confirmed by infiltration of immune cells into tumor tissues and immunodepleting-test using immunodepleting antibodies in syngeneic immunocompetent mouse models. Together with our recent study and here, the findings support that combination inhibition of SUMOylation and MEK comprehensively conquers MYC-expressing KRAS-mutant cancers by both immune-dependent and immune-independent antitumor responses., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
414. Neutral selection and clonal expansion during the development of colon cancer metastasis.
- Author
-
Lei X, Yamamoto D, Kitamura H, Kita K, Inaki N, Murakami K, Nakayama M, Oshima H, and Oshima M
- Subjects
- Humans, Animals, Mice, Organoids pathology, Organoids metabolism, Neoplasm Metastasis, Clonal Evolution, Colonic Neoplasms pathology, Colonic Neoplasms genetics, Colonic Neoplasms metabolism, Liver Neoplasms secondary, Liver Neoplasms pathology, Liver Neoplasms metabolism, Liver Neoplasms genetics
- Abstract
Intratumour heterogeneity has been shown to play a role in the malignant progression of cancer. The clonal evolution in primary cancer has been well studied, however, that in metastatic tumorigenesis is not fully understood. In this study, we established human colon cancer-derived organoids and investigated clonal dynamics during liver metastasis development by tracking barcode-labelled subclones. Long-term subclone co-cultures showed clonal drift, with a single subclone becoming dominant in the cell population. Interestingly, the selected subclones were not always the same, suggesting that clonal selection was not based on cell intrinsic properties. Furthermore, liver tumours developed by co-transplantation of organoid subclones into the immunodeficient mouse spleen showed a progressive drastic reduction in clonal diversity, and only one or two subclones predominated in the majority of large metastatic tumours. Importantly, selections were not limited to particular subclones but appeared to be random. A trend towards a reduction in clonal diversity was also found in liver metastases of multiple colour-labelled organoids of mouse intestinal tumours. Based on these results, we propose a novel mechanism of metastasis development, i.e. a subclone population of the disseminated tumour cells in the liver is selected by neutral selection during colonization and constitutes large metastatic tumours., (© The Author(s) 2024. Published by Oxford University Press on behalf of the Japanese Biochemical Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.)
- Published
- 2024
- Full Text
- View/download PDF
415. Disappearance of lens epithelial cells detected at the treatment of intraocular lens dislocation 12 months after cataract surgery: A case report.
- Author
-
Kurosaka D, Hashizume K, Oshima H, Miyoshi S, Itamochi M, and Kamei S
- Abstract
Purpose: To report a case of disappearance of lens epithelial cells (LECs) detected at the time of treatment for intraocular lens (IOL) dislocation 12 months after cataract surgery., Observations: A 59-year-old male underwent phacoemulsification with implantation of a posterior chamber acrylic IOL for posterior subcapsular cataract without any complications. Twelve months after cataract surgery, the IOL was dislocated inferiorly from the capsular bag due to rubbing the eye strongly, without capsular deviation. Fibrotic changes around the anterior capsular margin and posterior capsular opacification were not observed. During IOL repositioning, adhesions between the anterior and posterior capsules or zonule weakness were not observed. Six months after repositioning, the in-the-bag IOL dislocated into the anterior chamber because of zonular dialysis caused by strong eye rubbing again. Several days after scleral fixation of the IOL, the intraocular pressure decreased, possibly due to leakage from the wound. On inquiring about details, it was informed that the patient had a habit of sleeping in the prone position, with his face touching the pillow. After discontinuing this habit, his visual status stabilized., Conclusions and Importance: LEC may rarely disappear 12 months after cataract surgery. Although LEC survival is affected by various factors, minor trauma, such as slight eye rubbing and sleeping in a prone position, may influence IOL stability in the capsular bag and be related to early postoperative LEC disappearance., Competing Interests: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (© 2024 The Authors.)
- Published
- 2024
- Full Text
- View/download PDF
416. Isotropy of Cosmic Rays beyond 10^{20} eV Favors Their Heavy Mass Composition.
- Author
-
Abbasi RU, Abe Y, Abu-Zayyad T, Allen M, Arai Y, Arimura R, Barcikowski E, Belz JW, Bergman DR, Blake SA, Buckland I, Cheon BG, Chikawa M, Fujii T, Fujisue K, Fujita K, Fujiwara R, Fukushima M, Furlich G, Globus N, Gonzalez R, Hanlon W, Hayashida N, He H, Hibi R, Hibino K, Higuchi R, Honda K, Ikeda D, Inoue N, Ishii T, Ito H, Ivanov D, Iwasaki A, Jeong HM, Jeong S, Jui CCH, Kadota K, Kakimoto F, Kalashev O, Kasahara K, Kasami S, Kawakami S, Kawata K, Kharuk I, Kido E, Kim HB, Kim JH, Kim JH, Kim SW, Kimura Y, Komae I, Kuzmin V, Kuznetsov M, Kwon YJ, Lee KH, Lubsandorzhiev B, Lundquist JP, Matsumiya H, Matsuyama T, Matthews JN, Mayta R, Mizuno K, Murakami M, Myers I, Lee KH, Nagataki S, Nakai K, Nakamura T, Nishio E, Nonaka T, Oda H, Ogio S, Onishi M, Ohoka H, Okazaki N, Oku Y, Okuda T, Omura Y, Ono M, Oshima A, Oshima H, Ozawa S, Park IH, Park KY, Potts M, Pshirkov MS, Remington J, Rodriguez DC, Rott C, Rubtsov GI, Ryu D, Sagawa H, Saito R, Sakaki N, Sako T, Sakurai N, Sato D, Sato K, Sato S, Sekino K, Shah PD, Shibata N, Shibata T, Shikita J, Shimodaira H, Shin BK, Shin HS, Shinto D, Smith JD, Sokolsky P, Stokes BT, Stroman TA, Takagi Y, Takahashi K, Takamura M, Takeda M, Takeishi R, Taketa A, Takita M, Tameda Y, Tanaka K, Tanaka M, Tanoue Y, Thomas SB, Thomson GB, Tinyakov P, Tkachev I, Tokuno H, Tomida T, Troitsky S, Tsuda R, Tsunesada Y, Udo S, Urban F, Warren D, Wong T, Yamazaki K, Yashiro K, Yoshida F, Zhezher Y, and Zundel Z
- Abstract
We report an estimation of the injected mass composition of ultrahigh energy cosmic rays (UHECRs) at energies higher than 10 EeV. The composition is inferred from an energy-dependent sky distribution of UHECR events observed by the Telescope Array surface detector by comparing it to the Large Scale Structure of the local Universe. In the case of negligible extragalactic magnetic fields (EGMFs), the results are consistent with a relatively heavy injected composition at E∼10 EeV that becomes lighter up to E∼100 EeV, while the composition at E>100 EeV is very heavy. The latter is true even in the presence of highest experimentally allowed extragalactic magnetic fields, while the composition at lower energies can be light if a strong EGMF is present. The effect of the uncertainty in the galactic magnetic field on these results is subdominant.
- Published
- 2024
- Full Text
- View/download PDF
417. Dual inhibition of SUMOylation and MEK conquers MYC-expressing KRAS-mutant cancers by accumulating DNA damage.
- Author
-
Kotani H, Oshima H, Boucher JC, Yamano T, Sakaguchi H, Sato S, Fukuda K, Nishiyama A, Yamashita K, Ohtsubo K, Takeuchi S, Nishiuchi T, Oshima M, Davila ML, and Yano S
- Subjects
- Animals, Mice, Humans, Cell Line, Tumor, Mutation, Proto-Oncogene Proteins c-myc metabolism, Proto-Oncogene Proteins c-myc genetics, Sumoylation drug effects, DNA Damage drug effects, Proto-Oncogene Proteins p21(ras) genetics, Proto-Oncogene Proteins p21(ras) metabolism
- Abstract
Background: KRAS mutations frequently occur in cancers, particularly pancreatic ductal adenocarcinoma, colorectal cancer, and non-small cell lung cancer. Although KRAS
G12C inhibitors have recently been approved, effective precision therapies have not yet been established for all KRAS-mutant cancers. Many treatments for KRAS-mutant cancers, including epigenome-targeted drugs, are currently under investigation. Small ubiquitin-like modifier (SUMO) proteins are a family of small proteins covalently attached to and detached from other proteins in cells via the processes called SUMOylation and de-SUMOylation. We assessed whether SUMOylation inhibition was effective in KRAS-mutant cancer cells., Methods: The efficacy of the first-in-class SUMO-activating enzyme E inhibitor TAK-981 (subasumstat) was assessed in multiple human and mouse KRAS-mutated cancer cell lines. A gene expression assay using a TaqMan array was used to identify biomarkers of TAK-981 efficacy. The biological roles of SUMOylation inhibition and subsequent regulatory mechanisms were investigated using immunoblot analysis, immunofluorescence assays, and mouse models., Results: We discovered that TAK-981 downregulated the expression of the currently undruggable MYC and effectively suppressed the growth of MYC-expressing KRAS-mutant cancers across different tissue types. Moreover, TAK-981-resistant cells were sensitized to SUMOylation inhibition via MYC-overexpression. TAK-981 induced proteasomal degradation of MYC by altering the balance between SUMOylation and ubiquitination and promoting the binding of MYC and Fbxw7, a key factor in the ubiquitin-proteasome system. The efficacy of TAK-981 monotherapy in immunocompetent and immunodeficient mouse models using a mouse-derived CMT167 cell line was significant but modest. Since MAPK inhibition of the KRAS downstream pathway is crucial in KRAS-mutant cancer, we expected that co-inhibition of SUMOylation and MEK might be a good option. Surprisingly, combination treatment with TAK-981 and trametinib dramatically induced apoptosis in multiple cell lines and gene-engineered mouse-derived organoids. Moreover, combination therapy resulted in long-term tumor regression in mouse models using cell lines of different tissue types. Finally, we revealed that combination therapy complementally inhibited Rad51 and BRCA1 and accumulated DNA damage., Conclusions: We found that MYC downregulation occurred via SUMOylation inhibition in KRAS-mutant cancer cells. Our findings indicate that dual inhibition of SUMOylation and MEK may be a promising treatment for MYC-expressing KRAS-mutant cancers by enhancing DNA damage accumulation., (© 2024. The Author(s).)- Published
- 2024
- Full Text
- View/download PDF
418. GENESIS 2.1: High-Performance Molecular Dynamics Software for Enhanced Sampling and Free-Energy Calculations for Atomistic, Coarse-Grained, and Quantum Mechanics/Molecular Mechanics Models.
- Author
-
Jung J, Yagi K, Tan C, Oshima H, Mori T, Yu I, Matsunaga Y, Kobayashi C, Ito S, Ugarte La Torre D, and Sugita Y
- Abstract
GENeralized-Ensemble SImulation System (GENESIS) is a molecular dynamics (MD) software developed to simulate the conformational dynamics of a single biomolecule, as well as molecular interactions in large biomolecular assemblies and between multiple biomolecules in cellular environments. To achieve the latter purpose, the earlier versions of GENESIS emphasized high performance in atomistic MD simulations on massively parallel supercomputers, with or without graphics processing units (GPUs). Here, we implemented multiscale MD simulations that include atomistic, coarse-grained, and hybrid quantum mechanics/molecular mechanics (QM/MM) calculations. They demonstrate high performance and are integrated with enhanced conformational sampling algorithms and free-energy calculations without using external programs except for the QM programs. In this article, we review new functions, molecular models, and other essential features in GENESIS version 2.1 and discuss ongoing developments for future releases.
- Published
- 2024
- Full Text
- View/download PDF
419. Disease-specific autoantibody production in the lungs and salivary glands of anti-synthetase syndrome.
- Author
-
Takeshita M, Suzuki K, Nakazawa M, Kamata H, Ishii M, Oyamada Y, Oshima H, Usuda S, Tsunoda K, and Takeuchi T
- Subjects
- Humans, Female, Male, Middle Aged, Bronchoalveolar Lavage Fluid immunology, Adult, B-Lymphocytes immunology, Lung Diseases, Interstitial immunology, Autoantigens immunology, Antibodies, Antinuclear immunology, Aged, Salivary Glands immunology, Salivary Glands pathology, Autoantibodies immunology, Myositis immunology, Lung immunology, Lung pathology
- Abstract
Interstitial lung disease is a common complication of anti-synthetase syndrome (ASS), and lymphocytic infiltration is often observed in the lesion. We have recently reported that disease-specific autoantibodies are produced by infiltrating lymphocytes in some autoimmune diseases. Here, we investigate the antigen specificity of B cells in the lung lesions of ASS patients. A total of 177 antibodies were produced from antibody-secreting cells in bronchoalveolar fluid (BALF) of three each of serum anti-Jo-1 and serum anti-EJ antibody-positive patients. Twelve to 30% and 50 to 62% of these antibodies were disease-specific autoantibodies, respectively. These autoantibodies recognized conformational epitopes of the whole self-antigen and had affinity maturations, indicating that self-antigens themselves are the target of humoral immunity. In addition, 100 antibodies were produced from two salivary gland tissues, obtained by chance, of ASS patients. Salivary glands are not generally recognized as lesions of ASS, but unexpectedly, ASS-related autoantibody production was also observed similar to that of BALF. Immunostaining confirmed the presence of ASS-related autoantibody-producing cells in salivary glands. Our results suggest that disease-specific autoantibody production at lesion sites is a common pathogenesis of autoimmune diseases, and that tissue-specific production of autoantibodies can provide insights regarding the distribution of organ manifestations in autoimmune diseases., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2024 Takeshita, Suzuki, Nakazawa, Kamata, Ishii, Oyamada, Oshima, Usuda, Tsunoda and Takeuchi.)
- Published
- 2024
- Full Text
- View/download PDF
420. Effect of Recent Antirheumatic Drug on Features of Rheumatoid Arthritis-Associated Lymphoproliferative Disorders.
- Author
-
Hoshida Y, Tsujii A, Ohshima S, Saeki Y, Yagita M, Miyamura T, Katayama M, Kawasaki T, Hiramatsu Y, Oshima H, Murayama T, Higa S, Kuraoka K, Hirano F, Ichikawa K, Kurosawa M, Suzuki H, Chiba N, Sugiyama T, Minami Y, Niino H, Ihata A, Saito I, Mitsuo A, Maejima T, Kawashima A, Tsutani H, Takahi K, Kasai T, Shinno Y, Tachiyama Y, Teramoto N, Taguchi K, Naito S, Yoshizawa S, Ito M, Suenaga Y, Mori S, Nagakura S, Yoshikawa N, Nomoto M, Ueda A, Nagaoka S, Tsuura Y, Setoguchi K, Sugii S, Abe A, Sugaya T, Sugahara H, Fujita S, Kunugiza Y, Iizuka N, Yoshihara R, Yabe H, Fujisaki T, Morii E, Takeshita M, Sato M, Saito K, Matsui K, Tomita Y, Furukawa H, and Tohma S
- Subjects
- Humans, Male, Female, Middle Aged, Aged, Japan, Tacrolimus therapeutic use, Tacrolimus adverse effects, Drug Therapy, Combination, Epstein-Barr Virus Infections complications, Adult, Arthritis, Rheumatoid drug therapy, Arthritis, Rheumatoid complications, Antirheumatic Agents therapeutic use, Antirheumatic Agents adverse effects, Lymphoproliferative Disorders chemically induced, Methotrexate therapeutic use, Tumor Necrosis Factor Inhibitors therapeutic use, Tumor Necrosis Factor Inhibitors adverse effects
- Abstract
Objective: In this study, we examine how advancements in novel antirheumatic drugs affect the clinicopathologic features of lymphoproliferative disorder (LPD) in patients with rheumatoid arthritis (RA)., Methods: In this multicenter study across 53 hospitals in Japan, we characterized patients with RA who developed LPDs and visited the hospitals between January 1999 and March 2021. The statistical tools used included Fisher's exact test, the Mann-Whitney U-test, the log-rank test, logistic regression analysis, and Cox proportional hazards models., Results: Overall, 752 patients with RA-associated LPD (RA-LPD) and 770 with sporadic LPD were included in the study. We observed significant differences in the clinicopathologic features between patients with RA-LPD and those with sporadic LPD. Histopathological analysis revealed a high frequency of LPD-associated immunosuppressive conditions. Furthermore, patients with RA-LPD were evaluated based on the antirheumatic drugs administered. The methotrexate (MTX) plus tacrolimus and MTX plus tumor necrosis factor inhibitor (TNFi) groups had different affected site frequencies and histologic subtypes than the MTX-only group. Moreover, MTX and TNFi may synergistically affect susceptibility to Epstein-Barr virus infection. In case of antirheumatic drugs administered after LPD onset, tocilizumab (TCZ)-only therapy was associated with lower frequency of regrowth after spontaneous regression than other regimens., Conclusion: Antirheumatic drugs administered before LPD onset may influence the clinicopathologic features of RA-LPD, with patterns changing over time. Furthermore, TCZ-only regimens are recommended after LPD onset., (© 2024 The Authors. Arthritis & Rheumatology published by Wiley Periodicals LLC on behalf of American College of Rheumatology.)
- Published
- 2024
- Full Text
- View/download PDF
421. Subclinical structural atypicality of retinal thickness and its association with gray matter volume in the visual cortex of maltreated children.
- Author
-
Yao A, Nishitani S, Yamada Y, Oshima H, Sugihara Y, Makita K, Takiguchi S, Kawata NYS, Fujisawa TX, Okazawa H, Inatani M, and Tomoda A
- Subjects
- Humans, Child, Male, Adolescent, Female, Gray Matter diagnostic imaging, Gray Matter pathology, Retina pathology, Retina diagnostic imaging, Child Abuse, Magnetic Resonance Imaging methods, Visual Cortex diagnostic imaging, Visual Cortex pathology
- Abstract
Childhood maltreatment is reportedly associated with atypical gray matter structures in the primary visual cortex (V1). This study explores the hypothesis that retinal structures, the sensory organs of vision, are associated with brain atypicality and child maltreatment and examines their interrelation. General ophthalmologic examinations, visual cognitive tasks, retinal imaging, and structural magnetic resonance imaging (MRI) were conducted in children and adolescents aged 9-18 years with maltreatment experiences (CM) and typically developing (TD) children. The retinal nerve fiber layer (RNFL), the most superficial of the ten distinct retinal layers, was found to be significantly thinner in both eyes in CM. While whole-brain analysis using Voxel-based morphometry revealed a significantly larger gray matter volume (GMV) in the thalamus in CM, no significant correlation with RNFL thickness was observed. However, based on region-of-interest analysis, a thinner RNFL was associated with a larger GMV in the right V1. Although it cannot be ruled out that this outcome resulted from maltreatment alone, CM demonstrated subclinical structural atypicality in the retina, which may also correlate with the immaturity of V1 development. Examination of retinal thickness offers a novel clinical approach to capturing characteristics associated with childhood maltreatment., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
422. Identification of uromodulin deposition in the stroma of perinephric fibromyxoid nephrogenic adenoma by mass spectrometry.
- Author
-
Yoshimura K, Ito Y, Suzuki M, Horie M, Nishiuchi T, Shintani-Domoto Y, Shigehara K, Oshima H, Oshima M, Goto A, Nojima T, Tsuzuki T, Mizokami A, Ikeda H, and Maeda D
- Subjects
- Male, Humans, Aged, 80 and over, Uromodulin, Mass Spectrometry, Adenoma pathology
- Abstract
Nephrogenic adenoma (NA) is an epithelial lesion that usually occurs in the mucosa of the urinary tract. Rare cases of deep infiltrative or perinephric lesions have also been reported. Recently, NA with characteristic fibromyxoid stroma (fibromyxoid NA) has been proposed as a distinct variant. Although shedding of distal renal tubular cells due to urinary tract rupture has been postulated as the cause of NA in general, the mechanism underlying extraurinary presentation of NA and fibromyxoid stromal change in fibromyxoid NA remains unknown. In this study, we performed mass spectrometry (MS) analysis in a case of perinephric fibromyxoid NA of an 82-year-old man who underwent right nephroureterectomy for distal ureteral cancer. The patient had no prior history of urinary tract injury or radiation. Periodic acid-Schiff staining-positive eosinophilic structureless deposits in the stroma of fibromyxoid NA were microdissected and subjected to liquid chromatography/MS. The analysis revealed the presence of a substantial amount of uromodulin (Tamm-Horsfall protein). The presence of urinary content in the stroma of perinephric fibromyxoid NA suggests that urinary tract rupture and engraftment of renal tubular epithelial cells directly cause the lesion., (© 2024 Japanese Society of Pathology and John Wiley & Sons Australia, Ltd.)
- Published
- 2024
- Full Text
- View/download PDF
423. The primary ciliary dyskinesia-related genetic risk score is associated with susceptibility to adult-onset asthma.
- Author
-
Shigemasa R, Masuko H, Oshima H, Hyodo K, Kitazawa H, Kanazawa J, Yatagai Y, Iijima H, Naito T, Saito T, Konno S, Hirota T, Tamari M, Sakamoto T, and Hizawa N
- Subjects
- Adult, Humans, Female, Male, Genetic Risk Score, Lung pathology, Mucociliary Clearance, Asthma pathology, Ciliary Motility Disorders
- Abstract
Background: Disturbance of mucociliary clearance is an important factor in the pathogenesis of asthma. We hypothesized that common variants in genes responsible for ciliary function may contribute to the development of asthma with certain phenotypes., Methods: Three independent adult Japanese populations (including a total of 1,158 patients with asthma and 2,203 non-asthmatic healthy participants) were studied. First, based on the ClinVar database (https://www.ncbi.nlm.nih.gov/clinvar/), we selected 12 common single-nucleotide polymorphisms (SNPs) with molecular consequences (missense, nonsense, and 3'-untranslated region mutation) in 5 primary ciliary dyskinesia (PCD)-related genes and calculated a PCD-genetic risk score (GRS) as a cumulative effect of these PCD-related genes. Second, we performed a two-step cluster analysis using 3 variables, including PCD-GRS, forced expiratory volume in 1 second (%predicted FEV1), and age of asthma onset., Results: Compared to adult asthma clusters with an average PCD-GRS, clusters with high and low PCD-GRS had similar overall characteristics: adult-onset, female predominance, preserved lung function, and fewer features of type 2 immunity as determined by IgE reactivity and blood eosinophil counts. The allele frequency of rs1530496, a SNP representing an expression quantitative trait locus (eQTL) of DNAH5 in the lung, showed the largest statistically significant difference between the PCD-GRS-High and PCD-GRS-Low asthma clusters (p = 1.4 x 10-15)., Conclusion: Genes associated with PCD, particularly the common SNPs associated with abnormal expression of DNAH5, may have a certain influence on the development of adult-onset asthma, perhaps through impaired mucociliary clearance., Competing Interests: NH has received lecture fees and/or research funding from AstraZeneca, Boehringer Ingelheim, KYORIN Pharmaceutical, GlaxoSmithKline, Novartis, and Sanofi. The rest of the authors have no conflict of interest. This does not alter our adherence to PLOS ONE policies on sharing data and materials., (Copyright: © 2024 Shigemasa et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.)
- Published
- 2024
- Full Text
- View/download PDF
424. Gain-of-Function p53 Mutation Acts as a Genetic Switch for TGFβ Signaling-Induced Epithelial-to-Mesenchymal Transition in Intestinal Tumors.
- Author
-
Wang D, Nakayama M, Hong CP, Oshima H, and Oshima M
- Subjects
- Animals, Humans, Mice, Activins, Cell Line, Tumor, Epithelial-Mesenchymal Transition genetics, Gain of Function Mutation, Mutation, Tumor Suppressor Protein p53 genetics, Colorectal Neoplasms genetics, Transforming Growth Factor beta genetics, Transforming Growth Factor beta metabolism
- Abstract
Signaling by TGFβ family cytokines plays a tumor-suppressive role by inducing cell differentiation, while it promotes malignant progression through epithelial-to-mesenchymal transition (EMT). Identification of the mechanisms regulating the switch from tumor suppression to tumor promotion could identify strategies for cancer prevention and treatment. To identify the key genetic alterations that determine the outcome of TGFβ signaling, we used mouse intestinal tumor-derived organoids carrying multiple driver mutations in various combinations to examine the relationship between genotypes and responses to the TGFβ family cytokine activin A. KrasG12D mutation protected organoid cells from activin A-induced growth suppression by inhibiting p21 and p27 expression. Furthermore, Trp53R270H gain-of-function (GOF) mutation together with loss of wild-type Trp53 by loss of heterozygosity (LOH) promoted activin A-induced partial EMT with formation of multiple protrusions on the organoid surface, which was associated with increased metastatic incidence. Histologic analysis confirmed that tumor cells at the protrusions showed loss of apical-basal polarity and glandular structure. RNA sequencing analysis indicated that expression of Hmga2, encoding a cofactor of the SMAD complex that induces EMT transcription factors, was significantly upregulated in organoids with Trp53 GOF/LOH alterations. Importantly, loss of HMGA2 suppressed expression of Twist1 and blocked activin A-induced partial EMT and metastasis in Trp53 GOF/LOH organoids. These results indicate that TP53 GOF/LOH is a key genetic state that primes for TGFβ family-induced partial EMT and malignant progression of colorectal cancer. Activin signaling may be an effective therapeutic target for colorectal cancer harboring TP53 GOF mutations., Significance: KRAS and TP53 mutations shift activin-mediated signaling to overcome growth inhibition and promote partial EMT, identifying a subset of patients with colorectal cancer that could benefit from inhibition of TGFβ signaling., (©2023 The Authors; Published by the American Association for Cancer Research.)
- Published
- 2024
- Full Text
- View/download PDF
425. An In Vivo Metastasis Model Using Genotype-Defined Tumor Organoids.
- Author
-
Morita A, Nakayama M, Oshima H, and Oshima M
- Subjects
- Animals, Mice, Genotype, Disease Models, Animal, Tumor Suppressor Protein p53 genetics, Colorectal Neoplasms pathology, Colorectal Neoplasms genetics, Neoplasm Metastasis, Humans, Adenomatous Polyposis Coli Protein genetics, Receptor, Transforming Growth Factor-beta Type II genetics, Proto-Oncogene Proteins p21(ras) genetics, Epithelial-Mesenchymal Transition genetics, Organoids pathology, Mutation, Liver Neoplasms secondary, Liver Neoplasms genetics, Liver Neoplasms pathology
- Abstract
Recent cancer genome analyses have identified frequently mutated genes that are responsible for the development and malignant progression of cancers, including colorectal cancer (CRC). We previously constructed mouse models that carried major driver mutations of CRC, namely Apc, Kras, Tgfbr2, Trp53, and Fbxw7, in combinations. Comprehensive histological analyses of the models showed a link between mutation combinations and malignant phenotypes, such as invasion, epithelial-mesenchymal transition (EMT), and metastasis. The major cause of cancer-related death is metastasis, making it important to understand the mechanism underlying metastasis in order to develop novel therapeutic strategies. To this end, we have established intestinal tumor-derived organoids from different genotyped mice and generated liver metastasis models via transplantation of the organoids into the spleen. Through histological and imaging analyses of the transplantation models, we have determined that the combination of Apc, Kras, Tgfbr2, and Trp53 mutations promotes liver metastasis at a high incidence. We also demonstrated polyclonal metastasis of tumor cell clusters consisting of genetically and phenotypically distinct cells through our model analysis. These organoid transplantation models recapitulate human CRC metastasis, constituting a useful tool for basic and clinical cancer research as a preclinical model. We herein report the experimental protocols of the organoid culture and generation of metastasis models., (© 2024. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.)
- Published
- 2024
- Full Text
- View/download PDF
426. Successful treatment of PR3-ANCA-positive interstitial pneumonia with a moderate dose of glucocorticoid and rituximab.
- Author
-
Higashida-Konishi M, Akiyama M, Hama S, Oshige T, Izumi K, Oshima H, and Okano Y
- Subjects
- Male, Humans, Aged, 80 and over, Rituximab therapeutic use, Antibodies, Antineutrophil Cytoplasmic, Myeloblastin, Glucocorticoids therapeutic use, C-Reactive Protein, Fluorodeoxyglucose F18, Neoplasm Recurrence, Local drug therapy, Prednisolone therapeutic use, Lung Diseases, Interstitial diagnosis, Lung Diseases, Interstitial drug therapy, Lung Diseases, Interstitial etiology, Cysts drug therapy
- Abstract
Antineutrophil cytoplasmic antibody (ANCA)-positive interstitial pneumonia (IP) is reported as IP that is ANCA-positive and does not involve organ damage associated with vasculitis other than the lungs. While the combination of glucocorticoid and rituximab is effective in ANCA-associated vasculitis, the treatment strategy for ANCA-positive IP has not been established. Here, we report the first case of successful treatment of proteinase 3 (PR3)-ANCA-positive IP with a moderate dose of glucocorticoid and rituximab. The patient was an 80-year-old male who presented with subacute dry cough and dyspnoea. Blood tests revealed elevated levels of C-reactive protein, Krebs von den Lungen 6 (KL-6), and PR3-ANCA. Chest computed tomography (CT) showed interstitial shadows and infiltrates around honeycomb cysts. 18F-fluorodeoxyglucose (FDG) positron emission tomography CT revealed an uptake of FDG in the IP area. After starting treatment with a moderate dose of prednisolone and rituximab, the patient's clinical symptoms disappeared, C-reactive protein and KL-6 turned to be normal, and infiltrates around the cysts of honeycomb lungs disappeared. Prednisolone was gradually decreased to 2 mg, and no relapse or adverse events were observed during the course of treatment. Our case suggests that early treatment with a moderate dose of glucocorticoid and rituximab is effective for PR3-ANCA-positive IP., (© Japan College of Rheumatology 2023. Published by Oxford University Press.)
- Published
- 2023
- Full Text
- View/download PDF
427. Tympanic membrane findings and Eustachian tube function after transtympanic plugging for the chronic patulous Eustachian tube.
- Author
-
Kusano Y, Ikeda R, Kawamura Y, Oshima H, Nomura Y, Kikuchi T, Kawase T, Katori Y, and Kobayashi T
- Subjects
- Humans, Retrospective Studies, Tympanic Membrane surgery, Eustachian Tube, Ear Diseases surgery
- Abstract
Objective: To evaluate Eustachian tube (ET) function after Kobayashi plug surgery based on the tympanic membrane (TM) findings and active opening (AO) of the ET assessed with sonotubometry., Subjects and Methods: A retrospective survey of medical records identified 74 ears of 66 patients with patulous ET (PET) received transtympanic insertion of the Kobayashi plug. Excluding the six ears (6 patients) with abnormal preoperative TM, sixty-eight ears of 60 patients were found to have normal TM preoperatively. Among these 68 ears, there were 51 ears in which sonotubometry was performed both before and after surgery to evaluate whether the AO of the ET was positive or not., Results: Out of the 68 ears with normal preoperative TM, 52 ears (76.5%) were judged successful (sum of complete relief and significant improvement). The postoperative TM was normal in 41 ears (60.3%), while 27 ears (39.7%) had abnormal TM findings postoperatively. The success rate was 75.6% (31/41) in ears with normal postoperative TM, while it was 77.8% (21/27) in ears with abnormal TM. Success in maintaining normal postoperative TM was found in 45.6% (31/68) of the total ears treated. Out of the 51 ears in which sonotubometry was performed both before and after surgery, AO was preoperatively positive in 88.2% of the ears (45/51), while it was positive in 64.7% (33/51) postoperatively. In thirty-four ears with normal TM postoperatively, AO was positive in 24 ears (70.6%), while it was positive in 9 out of 17 ears (52.9%) with abnormal postoperative TM. The success rate was 70.6% (36/51) for the 51 ears in which AO was assessed both pre- and postoperatively, and it was 66.7% (22/33) in ears with positive AO postoperatively, while it was 77.8% (14/18) in ears without AO postoperatively. The incidence of ears either having normal postoperative TM or positive AO postoperatively was 84.3% (43/51). Abnormal postoperative TM findings without effectiveness were found in 8.8% (6/68)., Conclusion: The obstructive dysfunction of the ET is a calculated risk but did not occur in most ears after plugging with the Kobayashi plug. Therefore, routine insertion of the VT at the same time as the initial surgery is not recommended for PET cases that are adequately followed up., Competing Interests: Declaration of Competing Interest The authors declare no conflicts of interest., (Copyright © 2023. Published by Elsevier B.V.)
- Published
- 2023
- Full Text
- View/download PDF
428. An extremely energetic cosmic ray observed by a surface detector array.
- Author
-
Abbasi RU, Allen MG, Arimura R, Belz JW, Bergman DR, Blake SA, Shin BK, Buckland IJ, Cheon BG, Fujii T, Fujisue K, Fujita K, Fukushima M, Furlich GD, Gerber ZR, Globus N, Hibino K, Higuchi R, Honda K, Ikeda D, Ito H, Iwasaki A, Jeong S, Jeong HM, Jui CH, Kadota K, Kakimoto F, Kalashev OE, Kasahara K, Kawata K, Kharuk I, Kido E, Kim SW, Kim HB, Kim JH, Kim JH, Komae I, Kubota Y, Kuznetsov MY, Lee KH, Lubsandorzhiev BK, Lundquist JP, Matthews JN, Nagataki S, Nakamura T, Nakazawa A, Nonaka T, Ogio S, Ono M, Oshima H, Park IH, Potts M, Pshirkov S, Remington JR, Rodriguez DC, Rott C, Rubtsov GI, Ryu D, Sagawa H, Sakaki N, Sako T, Sakurai N, Shin H, Smith JD, Sokolsky P, Stokes BT, Stroman TS, Takahashi K, Takeda M, Taketa A, Tameda Y, Thomas S, Thomson GB, Tinyakov PG, Tkachev I, Tomida T, Troitsky SV, Tsunesada Y, Udo S, Urban FR, Wong T, Yamazaki K, Yuma Y, Zhezher YV, and Zundel Z
- Abstract
Cosmic rays are energetic charged particles from extraterrestrial sources, with the highest-energy events thought to come from extragalactic sources. Their arrival is infrequent, so detection requires instruments with large collecting areas. In this work, we report the detection of an extremely energetic particle recorded by the surface detector array of the Telescope Array experiment. We calculate the particle's energy as [Formula: see text] (~40 joules). Its arrival direction points back to a void in the large-scale structure of the Universe. Possible explanations include a large deflection by the foreground magnetic field, an unidentified source in the local extragalactic neighborhood, or an incomplete knowledge of particle physics.
- Published
- 2023
- Full Text
- View/download PDF
429. Atypical Cogan's Syndrome with Large-vessel Vasculitis Successfully Treated with Tocilizumab.
- Author
-
Higashida-Konishi M, Akiyama M, Tabata H, Hama S, Oshige T, Izumi K, Oshima H, and Okano Y
- Subjects
- Male, Humans, Middle Aged, Antibodies, Monoclonal, Humanized therapeutic use, Cogan Syndrome complications, Cogan Syndrome drug therapy, Cogan Syndrome diagnosis, Hearing Loss, Sensorineural drug therapy, Hearing Loss, Sensorineural etiology
- Abstract
A 61-year-old man presented with weight loss, bilateral ocular redness, blurred vision, and sensorineural hearing loss. Fluorodeoxyglucose-position emission tomography/computed tomography demonstrated an uptake in the ascending and descending aorta, abdominal aorta and femoral arteries. Atypical Cogan's syndrome complicated with large-vessel vasculitis (LVV) was diagnosed. He was treated with high-dose prednisolone and subcutaneous tocilizumab (162 mg/week), resulting in successful improvements in his ocular and vascular involvements. Although there is currently no established treatment strategy for LVV associated with Cogan's syndrome, our case and literature review suggest that tocilizumab is a viable treatment option for this rare but life-threatening complication.
- Published
- 2023
- Full Text
- View/download PDF
430. Factors associated with postsurgical muscle weakness in patients who undergo thoracic aortic surgery: a retrospective cohort study.
- Author
-
Shimizu M, Adachi T, Kobayashi K, Mutsuga M, Oshima H, Usui A, and Yamada S
- Subjects
- Humans, Aged, Retrospective Studies, Treatment Outcome, Knee Joint, Risk Factors, Muscle Weakness etiology, Aorta, Thoracic surgery
- Abstract
Objective: Aortic surgery is often performed in elderly patients, and these patients have a high risk of postsurgical muscle weakness. To reinforce purposeful postsurgical rehabilitation, we aimed to investigate the factors associated with postsurgical muscle weakness in patients who underwent thoracic aortic surgery., Methods: This retrospective cohort study analyzed data of consecutive patients who underwent elective thoracic aortic surgery with cardiopulmonary bypass, and whose knee extensor isometric muscle strength (KEIS) were measured pre- and postoperatively at University Hospital between January 2012 and December 2018. The primary outcome was percent change in KEIS (% change in KEIS). Multivariate linear regression analysis was used to identify independent risk factors for % change in KEIS., Results: Overall, 218 patients were included. Multivariate linear regression analysis showed that mechanical ventilation time, days from initial sitting to 100 m walking, and the number of exercises in the rehabilitation room were associated with % change in KEIS., Conclusions: This study may serve as a reference to stratify patients at risk of postsurgical muscle weakness. The preventive or alternative interventions in patients undergoing thoracic aortic surgery will be assessed in future studies.
- Published
- 2023
- Full Text
- View/download PDF
431. Genetic and nongenetic mechanisms for colorectal cancer evolution.
- Author
-
Kok SY, Nakayama M, Morita A, Oshima H, and Oshima M
- Subjects
- Animals, Mice, Mutation, Colorectal Neoplasms genetics, Colorectal Neoplasms pathology
- Abstract
The stepwise accumulation of key driver mutations is responsible for the development and malignant progression of colorectal cancer in primary sites. Genetic mouse model studies have revealed combinations of driver gene mutations that induce phenotypic changes in tumors toward malignancy. However, cancer evolution is regulated by not only genetic alterations but also nongenetic mechanisms. For example, certain populations of metastatic cancer cells show a loss of malignant characteristics even after the accumulation of driver mutations, and such cells are eliminated in a negative selection manner. Furthermore, a polyclonal metastasis model has recently been proposed, in which cell clusters consisting of genetically heterogeneous cells break off from the primary site, disseminate to distant organs, and develop into heterogenous metastatic tumors. Such nongenetic mechanisms for malignant progression have been elucidated using genetically engineered mouse models as well as organoid transplantation experiments. In this review article, we discuss the role of genetic alterations in the malignant progression of primary intestinal tumors and nongenetic mechanisms for negative selection and polyclonal metastasis, which we learned from model studies., (© 2023 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association.)
- Published
- 2023
- Full Text
- View/download PDF
432. Glibenclamide reduces secondary brain injury in a SAH rat model by reducing brain swelling and modulating inflammatory response.
- Author
-
Kajimoto R, Igarashi T, Moro N, Oshima H, Suma T, Otani N, and Yoshino A
- Subjects
- Rats, Animals, Glyburide pharmacology, Glyburide therapeutic use, Tumor Necrosis Factor-alpha therapeutic use, Rats, Sprague-Dawley, Endothelial Cells metabolism, Endothelial Cells pathology, Cytokines, Brain Edema drug therapy, Brain Edema etiology, Subarachnoid Hemorrhage drug therapy, Subarachnoid Hemorrhage complications, Brain Injuries drug therapy, Brain Injuries complications, Brain Neoplasms complications
- Abstract
Background: Early brain injury (EBI) after subarachnoid hemorrhage (SAH) is a new therapeutic target. Sulfonylurea receptor 1 (SUR1) is expressed in nerve cells, glial cells, and vascular endothelial cells in EBI. SUR1 promotes intracellular inflow of Na and Ca ions, resulting in cell swelling and depolarization, and finally cell death. Glibenclamide reduced cerebral edema and mortality in a basic study of cerebral ischemia. However, the effects of glibenclamide on EBI have not been fully elucidated. This study examined the inhibitory effect of glibenclamide on EBI., Methods: Rats were divided into the sham group, SAH-control group, and SAH-glibenclamide group. The water content of the brain was measured using the dry-wet method. In addition, the brain was divided into the cortex, putamen, and hippocampus, and expression of inflammatory cytokines was evaluated by the polymerase chain reaction method. In addition, microglia in the brain were evaluated immunohistologically., Results: Water content of the brain was significantly decreased in the SAH-glibenclamide group compared to the SAH-control group. Interleukin-1beta (IL-1β), tumor necrosis factor alpha (TNFα), and nuclear factor-kappa B significantly increased in the cerebral cortex after SAH. IL-1β and TNFα in the cortex were significantly decreased in the SAH-glibenclamide group compared to the SAH-control group. Immunohistochemical staining confirmed that SAH causes extensive microglial activation in the brain, which was suppressed by glibenclamide., Conclusions: The present study showed that glibenclamide suppressed cerebral edema and activation of microglia and hypersecretion of inflammatory cytokines. Glibenclamide is a potential therapeutic method which may significantly improve the functional prognosis.
- Published
- 2023
- Full Text
- View/download PDF
433. Inhibition of P2X4 and P2X7 receptors improves histological and behavioral outcomes after experimental traumatic brain injury in rats.
- Author
-
Kobayashi M, Moro N, Yoshino A, Kumagawa T, Shijo K, Maeda T, and Oshima H
- Abstract
Release of large amounts of adenosine triphosphate (ATP), a gliotransmitter, into the extracellular space by traumatic brain injury (TBI) is considered to activate the microglia followed by release of inflammatory cytokines resulting in excessive inflammatory response that induces secondary brain injury. The present study investigated whether antagonists of ATP receptors (P2X4 and/or P2X7) on microglia are beneficial for reducing the post-injury inflammatory response that leads to secondary injury, a prognostic aggravation factor of TBI. Adult male Sprague-Dawley rats were subjected to cortical contusion injury (CCI) and randomly assigned to injury and drug treatment conditions, as follows: i) No surgical intervention (naïve group); ii) dimethyl sulfoxide treatment after CCI (CCI-control group); iii) 5-BDBD (antagonist of P2X4 receptor) treatment after CCI (CCI-5-BDBD group); iv) CCI-AZ11645373 (antagonist of P2X7 receptor) treatment after CCI (CCI-AZ11645373 group); v) or 5-BDBD and AZ11645373 treatment after CCI (CCI-5-BDBD + AZ11645373 group). In the CCI-5-BDBD, CCI-AZ11645373, and CCI-5-BDBD + AZ11645373 groups, expression of activated microglia was suppressed in the ipsilateral cortex and hippocampus 3 days after the CCI. Western blotting with ionized calcium-binding adaptor molecule 1 antibody revealed that administration of CCI-5-BDBD and/or CCI-AZ11645373 suppressed expression of microglia and reduced expression of inflammatory cytokine mRNA 3 days after the CCI. Furthermore, the plus maze test, which reflects the spatial memory function and involves the hippocampal function, showed improvement 28 days after secondary injury to the hippocampus. These findings confirmed that blocking the P2X4 and P2X7 receptors, which are ATP receptors central in gliotransmission, suppresses microglial activation and subsequent cytokine expression after brain injury, and demonstrates the potential as an effective treatment for reducing secondary brain injury., Competing Interests: The authors declare that they have no competing interests., (Copyright: © Kobayashi et al.)
- Published
- 2023
- Full Text
- View/download PDF
434. Aseptic meningitis as an initial manifestation of primary Sjögren's syndrome.
- Author
-
Higashida-Konishi M, Akiyama M, Shimada T, Hama S, Oshige T, Izumi K, Oshima H, and Okano Y
- Subjects
- Male, Humans, Aged, 80 and over, Glucocorticoids therapeutic use, Antibodies, Meningitis, Aseptic etiology, Meningitis, Aseptic complications, Sjogren's Syndrome complications, Sjogren's Syndrome diagnosis
- Abstract
Aseptic meningitis is a rare life-threatening complication of primary Sjögren's syndrome (pSS), and its characteristics and prognosis remain unknown. We present our case of aseptic meningitis associated with pSS and reviewed the published literature to elucidate their characteristics and prognosis. An 84-year-old man was admitted to our hospital for fever and disturbance of consciousness. Acute aseptic meningitis was diagnosed based on the results for cerebrospinal fluid and head imaging tests. As an aetiological investigation for his aseptic meningitis, serum anti-Sjögren's-syndrome-related antigen A and anti-Sjögren's-syndrome-related antigen B antibodies were found to be positive, and the biopsy specimen of his labial salivary gland revealed lymphocytic sialadenitis, confirming a diagnosis of pSS. Treatment with moderate-dose glucocorticoid completely improved his aseptic meningitis. Relapse of the disease was not observed during his clinical course over 12 months. Our present case and literature review suggest that aseptic meningitis can be an initial manifestation of pSS and be treatable by immunosuppressive therapy. Thus, early recognition and treatment initiation are critical to prevent the irreversible damage of central nervous system in pSS-associated aseptic meningitis. In aseptic meningitis of unknown origin, pSS should be included in differential diagnoses, and testing for serum anti-Sjögren's-syndrome-related antigen A and anti-Sjögren's-syndrome-related antigen A antibodies may be useful as an initial screening., (© Japan College of Rheumatology 2022. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.)
- Published
- 2023
- Full Text
- View/download PDF
435. Giant cell arteritis successfully treated with subcutaneous tocilizumab monotherapy.
- Author
-
Higashida-Konishi M, Akiyama M, Shimada T, Hama S, Oshige T, Izumi K, Oshima H, and Okano Y
- Subjects
- Humans, Female, Aged, Positron Emission Tomography Computed Tomography, Fluorodeoxyglucose F18, Glucocorticoids therapeutic use, Pain drug therapy, Arthralgia drug therapy, Giant Cell Arteritis drug therapy, Polymyalgia Rheumatica drug therapy, Drug-Related Side Effects and Adverse Reactions
- Abstract
Glucocorticoid remains the mainstay for treatment of large vessel vasculitis (LVV) including giant cell arteritis (GCA); however, the disease affects the elderly for whom the adverse effects of glucocorticoid are problematic. Recently, some reports have suggested that intravenous tocilizumab (TCZ) monotherapy is effective for this disease. To date, it remains unknown whether subcutaneous TCZ monotherapy is also effective. Here, we present a first case of GCA successfully treated with subcutaneous TCZ monotherapy. A 75-year-old woman presented with shoulder and hip pain. She was diagnosed with polymyalgia rheumatica (PMR) and treated with low-dose prednisolone (15 mg daily); however, she discontinued glucocorticoid therapy at her discretion due to the psychiatric adverse effect (cognitive dysfunction). Seven months later, her shoulder and hip pain relapsed. Furthermore,
18 F-fluorodeoxyglucose (FDG)-positron emission tomography (PET)/computed tomography (CT) revealed uptake in the descending thoracic aorta, indicating a complication of LVV. She refused to take glucocorticoid for fear of psychiatric adverse effects and chose subcutaneous TCZ monotherapy (162 mg weekly) for treating this life-threatening urgent condition. Nine months later, her shoulder and hip pain resolved and FDG-PET/CT demonstrated no uptake in the descending thoracic aorta, indicating a successful treatment with subcutaneous TCZ monotherapy for the disease. No adverse events and disease relapse were found during observation period. Our case and the literature review suggest that not only intravenous injection but also subcutaneous injection of TCZ monotherapy can serve as an alternative treatment for patients with GCA who have comorbidities or refuse to take glucocorticoid., (© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.)- Published
- 2023
- Full Text
- View/download PDF
436. Mapping Nanomechanical Properties of Basal Surfaces in Metastatic Intestinal 3D Living Organoids with High-Speed Scanning Ion Conductance Microscopy.
- Author
-
Wang D, Nguyen HG, Nakayama M, Oshima H, Sun L, Oshima M, and Watanabe S
- Subjects
- Humans, Intestines, Organoids, Nanotechnology, Microscopy, Neoplasms pathology
- Abstract
Studying mechanobiology is increasing of scientific interests in life science and nanotechnology since its impact on cell activities (e.g., adhesion, migration), physiology, and pathology. The role of apical surface (AS) and basal surface (BS) of cells played in mechanobiology is significant. The mechanical mapping and analysis of cells mainly focus on AS while little is known about BS. Here, high-speed scanning ion conductance microscope as a powerful tool is utilized to simultaneously reveal morphologies and local elastic modulus (E) of BS of genotype-defined metastatic intestinal organoids. A simple method is developed to prepare organoid samples allowing for long-term BS imaging. The multiple nano/microstructures, i.e., ridge-like, stress-fiber, and E distributions on BS are dynamically revealed. The statistic E analysis shows softness of BS derived from eight types of organoids following a ranking: malignant tumor cells > benign tumor cells > normal cells. Moreover, the correlation factor between morphology and E is demonstrated depending on cell types. This work as first example reveals the subcellular morphologies and E distributions of BS of cells. The results would provide a clue for correlating genotype of 3D cells to malignant phenotype reflected by E and offering a promising strategy for early-stage diagnosis of cancer., (© 2022 The Authors. Small published by Wiley-VCH GmbH.)
- Published
- 2023
- Full Text
- View/download PDF
437. Pauli String Partitioning Algorithm with the Ising Model for Simultaneous Measurements.
- Author
-
Kurita T, Morita M, Oshima H, and Sato S
- Abstract
We propose an efficient algorithm for partitioning Pauli strings into subgroups, which can be simultaneously measured in a single quantum circuit. Our partitioning algorithm drastically reduces the total number of measurements in a variational quantum eigensolver for a quantum chemistry, one of the most promising applications of quantum computing. The algorithm is based on the Ising model optimization problem, which can be quickly solved using an Ising machine. We develop an algorithm that is applicable to problems with sizes larger than the maximum number of variables that an Ising machine can handle ( n
bit ) through its iterative use. The algorithm has much better time complexity and solution optimality than other existing algorithms. We investigate the performance of the algorithm using the second-generation Digital Annealer, a high-performance Ising hardware, for up to 65535 Pauli strings using Hamiltonians of molecules and the full tomography of quantum states. We demonstrate a time complexity of O ( N ) for N ≤ nbit and O ( N2 ) for N > nbit for the worst case, where N denotes the number of candidate Pauli strings and nbit = 8,192 in this study. The reduction factor, which is the number of Pauli strings divided by the number of obtained partitions, can be 200 at maximum.- Published
- 2023
- Full Text
- View/download PDF
438. Humoral and cellular responses to the third COVID-19 BNT162b2 vaccine dose in research institute workers in Japan.
- Author
-
Nishikimi A, Nakagawa T, Fujiwara M, Watanabe K, Watanabe A, Komatsu A, Yasuoka M, Watanabe R, Naya M, Oshima H, Kitagawa Y, Tokuda H, Kondo I, Niida S, Sakurai T, Kojima M, and Arai H
- Subjects
- Humans, COVID-19 Vaccines, Japan epidemiology, Academies and Institutes, Antibodies, Viral, BNT162 Vaccine, COVID-19 prevention & control
- Abstract
Competing Interests: Declarations of Competing Interest The authors declare no competing interests.
- Published
- 2023
- Full Text
- View/download PDF
439. Allergic disorders and their risk factors in primary Sjögren's syndrome.
- Author
-
Higashida-Konishi M, Izumi K, Shimada T, Hama S, Oshige T, Oshima H, and Okano Y
- Abstract
Objective: This study aimed to evaluate the prevalence of allergic disorders in patients with primary Sjögren's syndrome (pSS), compare it with that of patients with rheumatoid arthritis (RA), and examine the risk factors in patients with pSS., Methods: We retrospectively examined the records of patients diagnosed with pSS and RA who regularly visited our department between 2010 and 2020. Allergic disorders included drug allergy, food allergy, allergic contact dermatitis (ACD), allergic rhinitis (AR)/allergic conjunctivitis (AC), and asthma., Results: Patients with pSS (292 patients) had a higher prevalence of food allergy, drug allergy, and AR/AC than those with RA (413 patients). The multivariate analysis revealed that patients with pSS who had drug allergy had a higher prevalence of food allergy, higher eosinophil levels, and higher positivity rates of anti-SS-related antigen A (SSA) antibodies than those without drug allergy; those with food allergy had a higher rate of ACD than those without food allergy and vice versa; those with AR/AC had a higher rate of ACD and asthma and higher eosinophil levels than those without AR/AC; those with asthma had a higher rate of AR/AC than those without asthma., Conclusions: Patients with pSS had a higher prevalence of allergic disorders than those with RA. Among patients with pSS, the risk factors for drug allergy were food allergy, higher eosinophil levels, and positivity for anti-SSA antibodies, the risk factor for food allergy was ACD and vice versa, the risk factors for AR/AC were ACD, asthma, and high eosinophil levels, and the risk factor for asthma was AR/AC., (© 2023 The Author(s).)
- Published
- 2023
- Full Text
- View/download PDF
440. Successful treatment with tofacitinib for relapse of rapidly progressive interstitial lung disease in anti-melanoma differentiation-associated gene 5 antibody-positive clinically amyopathic dermatomyositis.
- Author
-
Hama S, Akiyama M, Higashida-Konishi M, Oshige T, Takei H, Izumi K, Oshima H, and Okano Y
- Subjects
- Humans, Interferon-Induced Helicase, IFIH1, Autoantibodies, Chronic Disease, Recurrence, Lung Diseases, Interstitial etiology, Lung Diseases, Interstitial complications
- Abstract
Anti-melanoma differentiation-associated gene 5 (MDA5) antibody is associated with clinically amyopathic dermatomyositis (CADM) with rapidly progressive interstitial lung disease (RP-ILD). Recently, several studies have reported that tofacitinib (TOF), a Janus kinase inhibitor, might be effective for cases of new or refractory RP-ILD in anti-MDA5 antibody-positive CADM; however, it is unknown whether TOF can also be effective for relapsed cases. We herein report a relapsed case of RP-ILD in anti-MDA5 antibody-positive CADM, which was successfully treated by combination therapy with TOF (5 mg twice daily). Our case suggests that TOF may also be a potential treatment option for relapsed cases of this disease., (© Japan College of Rheumatology 2022. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.)
- Published
- 2023
- Full Text
- View/download PDF
441. In Vitro and In Vivo Models for Metastatic Intestinal Tumors Using Genotype-Defined Organoids.
- Author
-
Morita A, Nakayama M, Oshima H, and Oshima M
- Subjects
- Mice, Animals, Intestines pathology, Models, Biological, Genotype, Organoids pathology, Intestinal Neoplasms genetics, Intestinal Neoplasms pathology, Colorectal Neoplasms genetics, Colorectal Neoplasms pathology
- Abstract
It has been established that the accumulation of driver gene mutations causes malignant progression of colorectal cancer (CRC) through positive selection and clonal expansion, similar to Darwin's evolution. Following this multistep tumorigenesis concept, we previously showed the specific mutation patterns for each process of malignant progression, including submucosal invasion, epithelial mesenchymal transition (EMT), intravasation, and metastasis, using genetically engineered mouse and organoid models. However, we also found that certain populations of cancer-derived organoid cells lost malignant characteristics of metastatic ability, although driver mutations were not impaired, and such subpopulations were eliminated from the tumor tissues by negative selection. These organoid model studies have contributed to our understanding of the cancer evolution mechanism. We herein report the in vitro and in vivo experimental protocols to investigate the survival, growth, and metastatic ability of intestinal tumor-derived organoids. The model system will be useful for basic research as well as the development of clinical strategies., (© 2023. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.)
- Published
- 2023
- Full Text
- View/download PDF
442. Use of multistate Bennett acceptance ratio method for free-energy calculations from enhanced sampling and free-energy perturbation.
- Author
-
Matsunaga Y, Kamiya M, Oshima H, Jung J, Ito S, and Sugita Y
- Abstract
Multistate Bennett acceptance ratio (MBAR) works as a method to analyze molecular dynamics (MD) simulation data after the simulations have been finished. It is widely used to estimate free-energy changes between different states and averaged properties at the states of interest. MBAR allows us to treat a wide range of states from those at different temperature/pressure to those with different model parameters. Due to the broad applicability, the MBAR equations are rather difficult to apply for free-energy calculations using different types of MD simulations including enhanced conformational sampling methods and free-energy perturbation. In this review, we first summarize the basic theory of the MBAR equations and categorize the representative usages into the following four: (i) perturbation, (ii) scaling, (iii) accumulation, and (iv) full potential energy. For each, we explain how to prepare input data using MD simulation trajectories for solving the MBAR equations. MBAR is also useful to estimate reliable free-energy differences using MD trajectories based on a semi-empirical quantum mechanics/molecular mechanics (QM/MM) model and ab initio QM/MM energy calculations on the MD snapshots. We also explain how to use the MBAR software in the GENESIS package, which we call mbar_analysis , for the four representative cases. The proposed estimations of free-energy changes and thermodynamic averages are effective and useful for various biomolecular systems., Competing Interests: Competing interests.The authors declare no competing interests., (© The Author(s) 2022.)
- Published
- 2022
- Full Text
- View/download PDF
443. Risk factors associated with cytomegalovirus reactivation in patients receiving immunosuppressive therapy for rheumatic diseases: a retrospective study.
- Author
-
Shimada T, Higashida-Konishi M, Izumi K, Hama S, Oshige T, Oshima H, and Okano Y
- Subjects
- Humans, Retrospective Studies, Cytomegalovirus, Creatinine, Immunosuppression Therapy, Prednisolone adverse effects, Immunosuppressive Agents adverse effects, Risk Factors, Hypoalbuminemia, Rheumatic Diseases drug therapy, Cyclosporins, Cytomegalovirus Infections
- Abstract
Immunosuppressive treatment is a common cause of cytomegalovirus (CMV) reactivation. However, there is no consensus regarding the risk factors for CMV reactivation in rheumatic diseases. Therefore, this study aimed to elucidate the risk factors associated with CMV reactivation. We retrospectively collected the data of 472 patients with rheumatic diseases whose CMV pp65 antigen (C7-HRP) titer was measured. We divided the patients into those with and those without C7-HRP. We retrospectively collected data on age, sex, primary condition and organ involvement, and blood test results. We also investigated the use of immunosuppressants and the maximum and cumulative doses of prednisolone (PSL). We performed univariate and multivariate analyses to identify risk factors for CMV reactivation. Multivariate analysis showed that higher age (71.2 vs. 64.4 years, p = 0.0022), hypoalbuminemia (2.9 vs. 3.4 g/dL, p = 0.0104), higher creatinine level (1.2 vs. 0.9 mg/dL, p = 0.0026), cyclosporine use (8.2 vs. 3.6%, p = 0.0101), and higher maximum (552.4 vs. 243.3 mg, p < 0.0001) and cumulative (2785.9 vs. 1330.5 mg, p < 0.0001) doses of PSL were associated with CMV reactivation. Older age, hypoalbuminemia, higher creatinine level, cyclosporine use, and higher maximum and cumulative doses of PSL were significant risk factors for CMV reactivation in rheumatic diseases., (© 2022. The Author(s).)
- Published
- 2022
- Full Text
- View/download PDF
444. Glibenclamide attenuates brain edema associated with microglia activation after intracerebral hemorrhage.
- Author
-
Shiokawa R, Otani N, Kajimoto R, Igarashi T, Moro N, Suma T, Oshima H, and Yoshino A
- Subjects
- Animals, Rats, Cerebral Hemorrhage drug therapy, Galectin 3, Glyburide pharmacology, Glyburide therapeutic use, Hematoma, Microglia, Brain Edema drug therapy, Brain Edema etiology
- Abstract
Objective: Glibenclamide, Sulfonylurea receptor 1 antagonist, reduces brain edema after cerebral hemorrhage. However, the effects of glibenclamide on microglial activation and inflammatory cell infiltration after cerebral hemorrhage are unclear. The present study investigated the effect of glibenclamide on microglial activation and inflammatory cell infiltration in a rat cerebral hemorrhage model., Methods: A collagenase intracerebral injection model was used to cause cerebral hemorrhage in rats. After injury, glibenclamide was continuously administered at 1.0μL/h for 24hours. We evaluated hematoma volume, brain edema, expression of ABCC8, galectin-3 and CD11b, and anti-Iba-1 antibody staining., Results: Glibenclamide significantly reduced water content. Meanwhile, glibenclamide significantly reduced expression of galectin-3 and CD11b in the cerebral cortex and putamen on the bleeding side. Immunohistochemical staining confirmed that glibenclamide attenuated activation of microglia around the hematoma., Conclusions: Glibenclamide reduced microglial activation and infiltration of inflammatory cells, resulting in amelioration of cerebral edema., (Copyright © 2022 Elsevier Masson SAS. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
445. Usefulness of malignant pleural effusion for early cytological diagnosis of mesothelioma in situ : A case report.
- Author
-
Yabuuchi Y, Hiroshima K, Oshima H, Kanazawa J, Hayashihara K, Nakagawa T, Shimanouchi M, Usui S, Oh-Ishi S, Saito T, Hizawa N, and Minami Y
- Abstract
Mesothelioma in situ (MIS) is defined as a preinvasive mesothelioma that forms a single layer of mild atypical mesothelial cells lining on the serosa surface of pleura. The atypical mesothelial cells present loss of BRCA-1 associated protein-1 (BAP-1) and/or methylthioadenosine phosphorylase as examined by immunohistochemistry (IHC) and/or homozygous deletion of cyclin-dependent kinase inhibitor 2A/p16 as examined by fluorescence in situ hybridization. It is difficult to diagnose because of the unremarkable clinical findings except for pleural effusion. The present report describes a case in which MIS was diagnosed at the time of sampling due to the presence of clearly malignant mesothelial cells in the pleural fluid. In 2016, a 74-year-old man with a history of past exposure to asbestos was admitted to Ibaraki Higashi National Hospital (Tokai-mura, Japan) with dyspnea. Chest CT indicated only right pleural effusion. Malignant mesothelial cells were suspected in a cell block made using pleural effusion; therefore, right pleural biopsy was performed. Pathologically, there was proliferation of mesothelial cells with mild atypia that formed a single-flat layer on the pleural surface; however, there was no invasion. Furthermore, IHC revealed loss of BAP-1 in cells from the biopsied pleura and pleural effusion. MIS was suspected at the time; however, the patient arbitrarily quit his medical check-ups. After 44 months, the patient was readmitted to our hospital complaining of dyspnea. CT indicated a large right pleural mass. A specimen of the mass obtained via CT-guided needle biopsy revealed malignant mesothelioma. The patient continued to deteriorate and eventually died. This case indicated that pleural effusion could be used to demonstrate overtly malignant mesothelial cells and diagnose MIS at the time of sampling. To the best of our knowledge, this is first report of MIS with overtly malignant mesothelial cells in pleural effusion. Pleural effusion may serve an important role in MIS diagnosis., Competing Interests: The authors declare that they have no competing interests., (Copyright: © Yabuuchi et al.)
- Published
- 2022
- Full Text
- View/download PDF
446. Modified Protein-Water Interactions in CHARMM36m for Thermodynamics and Kinetics of Proteins in Dilute and Crowded Solutions.
- Author
-
Matsubara D, Kasahara K, Dokainish HM, Oshima H, and Sugita Y
- Subjects
- Molecular Dynamics Simulation, Peptides, Thermodynamics, Intrinsically Disordered Proteins chemistry, Water chemistry
- Abstract
Proper balance between protein-protein and protein-water interactions is vital for atomistic molecular dynamics (MD) simulations of globular proteins as well as intrinsically disordered proteins (IDPs). The overestimation of protein-protein interactions tends to make IDPs more compact than those in experiments. Likewise, multiple proteins in crowded solutions are aggregated with each other too strongly. To optimize the balance, Lennard-Jones (LJ) interactions between protein and water are often increased about 10% (with a scaling parameter, λ = 1.1) from the existing force fields. Here, we explore the optimal scaling parameter of protein-water LJ interactions for CHARMM36m in conjunction with the modified TIP3P water model, by performing enhanced sampling MD simulations of several peptides in dilute solutions and conventional MD simulations of globular proteins in dilute and crowded solutions. In our simulations, 10% increase of protein-water LJ interaction for the CHARMM36m cannot maintain stability of a small helical peptide, (AAQAA)
3 in a dilute solution and only a small modification of protein-water LJ interaction up to the 3% increase (λ = 1.03) is allowed. The modified protein-water interactions are applicable to other peptides and globular proteins in dilute solutions without changing thermodynamic properties from the original CHARMM36m. However, it has a great impact on the diffusive properties of proteins in crowded solutions, avoiding the formation of too sticky protein-protein interactions.- Published
- 2022
- Full Text
- View/download PDF
447. Immune-mediated necrotizing myopathy which showed deposition of C5b-9 in the necrotic muscle fibers and was successfully treated with intensive combined therapy with high-dose glucocorticoids, tacrolimus, and intravenous immunoglobulins.
- Author
-
Shimada T, Higashida-Konishi M, Akiyama M, Hama S, Izumi K, Matsubara S, Oshima H, and Okano Y
- Subjects
- Autoantibodies, Complement Membrane Attack Complex, Female, Glucocorticoids, Humans, Immunoglobulins, Intravenous, Muscle Fibers, Skeletal pathology, Tacrolimus, Autoimmune Diseases, Muscular Diseases complications, Muscular Diseases diagnosis, Muscular Diseases pathology, Myositis complications, Myositis drug therapy
- Abstract
Currently, no standard treatment strategy has been established for immune-mediated necrotizing myopathy (IMNM). Here we present a case of IMNM which was successfully treated with intensive combined therapy with high-dose glucocorticoids, tacrolimus, and intravenous immunoglobulins. Her muscle weakness was rapidly progressive and severe so that she became bedridden one week after admission. She was complicated with dysphagia and had serum myogenic enzymes elevation, ventricular diastolic dysfunction, and interstitial lung disease. Serum anti-SRP antibody was positive and her muscle biopsy revealed many necrotic fibers with minimal inflammation. Further histological analysis demonstrated infiltration of phagocytic macrophages with deposition of membrane attack complex (C5b-9) in the necrotic muscle fibers, suggesting activation of complement pathway and macrophages as a pathomechanism of this disease. She was diagnosed as IMNM and was immediately initiated a combination therapy described above, which led to dramatic clinical improvements. Recent studies suggest that intravenous immunoglobulins and tacrolimus can inhibit the activation of complement pathway and macrophages. Our present case suggests that early initiation of intensive combined therapy including intravenous immunoglobulins and tacrolimus might be effective for preventing irreversible muscle damages by disrupting a pathogenic activation of complement and macrophages in IMNM.
- Published
- 2022
- Full Text
- View/download PDF
448. State and Economic Enterprise in Japan
- Author
-
Lockwood, William W., Edited by, BRONFENENNER, M., CRAWCOUR, E. SYDNEY, GLEASON, ALAN H., HIRSCHMEIER, J., HORIE, YASUZŌ, LANDES, DAVID S., LEVINE, SOLOMON B., LOCKWOOD, W. W., NAKAMURA, JAMES I., OHKAWA, KAZUSHI, ŌKITA, SABURO, OSHIMA, HARRY T., PATRICK, HUGH T., ROSOVSKY, HENRY, SCALAPINO, ROBERT A., SAWADA, SHŪJIRŌ, Lockwood, William W., BRONFENENNER, M., CRAWCOUR, E. SYDNEY, GLEASON, ALAN H., HIRSCHMEIER, J., HORIE, YASUZŌ, LANDES, DAVID S., LEVINE, SOLOMON B., LOCKWOOD, W. W., NAKAMURA, JAMES I., OHKAWA, KAZUSHI, ŌKITA, SABURO, OSHIMA, HARRY T., PATRICK, HUGH T., ROSOVSKY, HENRY, SCALAPINO, ROBERT A., and SAWADA, SHŪJIRŌ
- Published
- 2015
- Full Text
- View/download PDF
449. Glycemic Control after Initiation of Anti-VEGF Treatment for Diabetic Macular Edema.
- Author
-
Oshima H, Takamura Y, Hirano T, Shimura M, Sugimoto M, Kida T, Matsumura T, Gozawa M, Yamada Y, Morioka M, and Inatani M
- Abstract
Diabetic macular edema (DME) induces visual disturbance, and intravitreal injections of anti-vascular endothelial growth factor (VEGF) drugs are the accepted first-line treatment. We investigate its impact on glycemic control after starting VEGF treatment for DME on the basis of a questionnaire and changes in hemoglobin A1c (HbA1c). We conducted a retrospective multicenter study analyzing 112 patients with DME who underwent anti-VEGF therapy and their changes in HbA1c over two years. Central retinal thickness and visual acuity significantly improved at three months and throughout the period after initiating therapy (p < 0.0001); a significant change in HbA1c was not found. A total of 59.8% of patients became more active in glycemic control through exercise and diet therapy after initiating therapy, resulting in a significantly lower HbA1c at 6 (p = 0.0047), 12 (p = 0.0003), and 18 (p = 0.0117) months compared to patients who did not. HbA1c was significantly lower after 18 months in patients who stated that anti-VEGF drugs were expensive (p = 0.0354). The initiation of anti-VEGF therapy for DME affects HbA1c levels in relation to more aggressive glycemic control.
- Published
- 2022
- Full Text
- View/download PDF
450. Dropped head in systemic sclerosis: a case based review.
- Author
-
Shimada T, Higashida-Konishi M, Akiyama M, Hama S, Takei H, Izumi K, Oshima H, and Okano Y
- Subjects
- Antibodies, Antinuclear, Contrast Media, Creatine Kinase, Gadolinium therapeutic use, Humans, Male, Muscle Weakness etiology, Muscular Diseases complications, Scleroderma, Systemic complications, Scleroderma, Systemic drug therapy
- Abstract
Dropped head syndrome is a rare disease entity characterized by severe weakness of the cervical para-spinal muscles, resulting in a chin-on-chest deformity. Systemic sclerosis is one of the causes of dropped head syndrome, but its characteristics and prognosis remain unclear due to the extreme rarity of this condition. We present a case of dropped head which occurred in systemic sclerosis. He presented with severe dropped head and relatively mild weakness of the proximal limb muscles. Serum level of creatine kinase was elevated, myopathic change was observed in electromyography, and gadolinium enhancement was found in magnetic resonance imaging of his posterior neck muscles. Anti-topoisomerase I antibody was positive, while other autoantibodies such as anti-PM/Scl and anti-Ku antibodies were negative. Since his dropped head acutely progressed, high dose of glucocorticoid therapy was initiated, which successfully improved dropped head, serum level of creatine kinase, and gadolinium enhancement in magnetic resonance imaging. Our present case and literature review suggest that dropped head occurring in systemic sclerosis can be treatable with immunosuppressive therapy. It is important to recognize this rare but treatable involvement of systemic sclerosis because early diagnosis and treatment initiation are crucial to prevent the irreversible organ damage and the significant decrease of daily activities., (© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.)
- Published
- 2022
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.